Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06722365 · ClinicalTrials.gov registry record

Characterization of Fetal Lung With Quantitative Ultrasound

A clinical trial of Respiratory Complication and Fetal Lung Imaging, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
16
Enrollment target
1
Study location

NCT06722365: Recruiting study of Respiratory Complication and Fetal Lung Imaging, sponsored by University of Wisconsin, Madison.

NCT06722365 is a study of Respiratory Complication and Fetal Lung Imaging that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 16 participants, below the 138-participant average among 3 other Respiratory Complication trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06722365, a study of Respiratory Complication and Fetal Lung Imaging, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to show if it's possible to use a special kind of ultrasound called backscatter quantitative ultrasound (bQUS) to check on a baby's lungs when the mother is 36 weeks pregnant. 16 participants will be on study for a single 30 minute ultrasound between 32 and 36 weeks of pregnancy.

Primary Outcome

Phase 1 will provide evidence of the technical viability of data acquisition at the UPH-Meriter CPC and will involve 5 participants. Technical challenges will be discussed with the research team and the supporting vendor (GE) to decide whether the technique is viable to move forward. In case the decision is favorable, recruitment will continue to complete 16 participants to estimate the populational variance of the quantitative features. If the decision is not favorable due to technical complica

Interventions

  • DEVICE Backscatter Quantitative Ultrasound

Study Locations (1)

Wisconsin

  • Meriter Hospital - Madison

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2024-12-17
Est. Completion 2026-06
University of Wisconsin, Madison

1,039 total trials

What NCT06722365 shows while recruiting

NCT06722365 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 138-participant average among 3 other Respiratory Complication trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Respiratory Complication appearing as the primary indexed condition, and to 1 intervention - of which Backscatter Quantitative Ultrasound is the first listed.

NCT06722365 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06722365 about?

NCT06722365 is a clinical study titled "Characterization of Fetal Lung With Quantitative Ultrasound". The purpose of the study is to show if it's possible to use a special kind of ultrasound called backscatter quantitative ultrasound (bQUS) to check on a baby's lungs when the mother is 36 weeks pregnant. 16 participants will be on study for a single 30 minute ultrasound between 32 and 36 weeks of pr...

What is the current status of trial NCT06722365?

This trial is currently recruiting. The enrollment target is 16 participants. The study started on 2024-12-17. Estimated completion is 2026-06.

What conditions does trial NCT06722365 study?

This clinical trial studies the following conditions: Respiratory Complication, Fetal Lung Imaging.

What interventions are being tested in trial NCT06722365?

The interventions under investigation include: Backscatter Quantitative Ultrasound (DEVICE).

Who is sponsoring clinical trial NCT06722365?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06722365 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Complication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06722365, the US trial registry maintained by the National Library of Medicine. NCT06722365 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.